Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Micafungin (Mycamine®) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (MICADO).

NCT03102658 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03102658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03102658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Micafungin (Mycamine®) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (MICADO).
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2017
Completion date
July 31, 2017
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

morbid obesity